View ValuationChemplast Sanmar 향후 성장Future 기준 점검 3/6Chemplast Sanmar (는) 각각 연간 96.7% 및 10.2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 96.3% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 8.7% 로 예상됩니다.핵심 정보96.7%이익 성장률96.30%EPS 성장률Chemicals 이익 성장17.7%매출 성장률10.2%향후 자기자본이익률8.65%애널리스트 커버리지Low마지막 업데이트08 Jul 2026최근 향후 성장 업데이트Price Target Changed • May 27Price target decreased by 18% to ₹302Down from ₹366, the current price target is an average from 4 analysts. New target price is 36% above last closing price of ₹222. Stock is down 49% over the past year. The company is forecast to post a net loss per share of ₹3.17 next year compared to a net loss per share of ₹17.70 last year.Price Target Changed • Feb 10Price target decreased by 12% to ₹380Down from ₹434, the current price target is an average from 4 analysts. New target price is 34% above last closing price of ₹283. Stock is down 35% over the past year. The company is forecast to post a net loss per share of ₹21.00 next year compared to a net loss per share of ₹6.98 last year.Price Target Changed • Nov 18Price target decreased by 14% to ₹474Down from ₹553, the current price target is an average from 4 analysts. New target price is 45% above last closing price of ₹327. Stock is down 33% over the past year. The company is forecast to post a net loss per share of ₹5.55 next year compared to a net loss per share of ₹6.98 last year.Price Target Changed • Oct 13Price target increased by 9.9% to ₹553Up from ₹503, the current price target is an average from 4 analysts. New target price is 51% above last closing price of ₹366. Stock is down 26% over the past year. The company is forecast to post earnings per share of ₹3.00 next year compared to a net loss per share of ₹6.98 last year.Price Target Changed • Jun 19Price target increased by 8.8% to ₹582Up from ₹535, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₹581. Stock is up 30% over the past year. The company is forecast to post earnings per share of ₹14.05 next year compared to a net loss per share of ₹10.02 last year.Price Target Changed • Nov 04Price target decreased by 7.1% to ₹568Down from ₹612, the current price target is an average from 3 analysts. New target price is 27% above last closing price of ₹447. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₹12.40 for next year compared to ₹9.64 last year.모든 업데이트 보기Recent updatesReported Earnings • Jul 16Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: ₹17.70 loss per share (further deteriorated from ₹6.98 loss in FY 2025). Revenue: ₹42.2b (down 2.8% from FY 2025). Net loss: ₹2.80b (loss widened 154% from FY 2025). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 4.3%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.Board Change • Jun 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. MD & Director S Ganeshkumar was the last director to join the board, commencing their role in 2026. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Price Target Changed • May 27Price target decreased by 18% to ₹302Down from ₹366, the current price target is an average from 4 analysts. New target price is 36% above last closing price of ₹222. Stock is down 49% over the past year. The company is forecast to post a net loss per share of ₹3.17 next year compared to a net loss per share of ₹17.70 last year.공고 • May 26Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2026Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2026.Reported Earnings • May 26Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: ₹17.70 loss per share (further deteriorated from ₹6.98 loss in FY 2025). Revenue: ₹42.5b (down 2.2% from FY 2025). Net loss: ₹2.80b (loss widened 154% from FY 2025). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 4.3%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.공고 • May 19Chemplast Sanmar Limited to Report Q4, 2026 Results on May 25, 2026Chemplast Sanmar Limited announced that they will report Q4, 2026 results on May 25, 2026Board Change • Apr 16Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. Non-Executive Independent Director Vikram Hosangady was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Buy Or Sell Opportunity • Mar 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.0% to ₹258. The fair value is estimated to be ₹325, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.1% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Feb 27Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 14% to ₹246. The fair value is estimated to be ₹307, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.1% over the last 3 years. Meanwhile, the company became loss making.Price Target Changed • Feb 10Price target decreased by 12% to ₹380Down from ₹434, the current price target is an average from 4 analysts. New target price is 34% above last closing price of ₹283. Stock is down 35% over the past year. The company is forecast to post a net loss per share of ₹21.00 next year compared to a net loss per share of ₹6.98 last year.Reported Earnings • Feb 09Third quarter 2026 earnings: EPS and revenues miss analyst expectationsThird quarter 2026 results: ₹7.45 loss per share (further deteriorated from ₹3.06 loss in 3Q 2025). Revenue: ₹8.35b (down 21% from 3Q 2025). Net loss: ₹1.19b (loss widened 144% from 3Q 2025). Revenue missed analyst estimates by 26%. Earnings per share (EPS) also missed analyst estimates by 28%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance.공고 • Feb 02Chemplast Sanmar Limited to Report Q3, 2026 Results on Feb 07, 2026Chemplast Sanmar Limited announced that they will report Q3, 2026 results at 12:08 PM, Indian Standard Time on Feb 07, 2026New Risk • Jan 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.4% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change).Price Target Changed • Nov 18Price target decreased by 14% to ₹474Down from ₹553, the current price target is an average from 4 analysts. New target price is 45% above last closing price of ₹327. Stock is down 33% over the past year. The company is forecast to post a net loss per share of ₹5.55 next year compared to a net loss per share of ₹6.98 last year.공고 • Nov 11Chemplast Sanmar Limited to Report Q2, 2026 Results on Nov 13, 2025Chemplast Sanmar Limited announced that they will report Q2, 2026 results at 12:08 PM, Indian Standard Time on Nov 13, 2025공고 • Oct 28Chemplast Sanmar Limited to Report Q2, 2026 Results on Nov 04, 2025Chemplast Sanmar Limited announced that they will report Q2, 2026 results on Nov 04, 2025Price Target Changed • Oct 13Price target increased by 9.9% to ₹553Up from ₹503, the current price target is an average from 4 analysts. New target price is 51% above last closing price of ₹366. Stock is down 26% over the past year. The company is forecast to post earnings per share of ₹3.00 next year compared to a net loss per share of ₹6.98 last year.공고 • Jul 22Chemplast Sanmar Limited to Report Q1, 2026 Results on Jul 28, 2025Chemplast Sanmar Limited announced that they will report Q1, 2026 results on Jul 28, 2025Reported Earnings • Jul 22Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: ₹6.98 loss per share (improved from ₹10.02 loss in FY 2024). Revenue: ₹43.5b (up 11% from FY 2024). Net loss: ₹1.10b (loss narrowed 30% from FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 65%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance.공고 • May 14Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2025Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2025.Reported Earnings • May 14Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: ₹6.92 loss per share (improved from ₹10.02 loss in FY 2024). Revenue: ₹43.9b (up 12% from FY 2024). Net loss: ₹1.10b (loss narrowed 30% from FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 65%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 114 percentage points per year, which is a significant difference in performance.공고 • May 10Chemplast Sanmar Limited to Report Q4, 2025 Results on May 13, 2025Chemplast Sanmar Limited announced that they will report Q4, 2025 results on May 13, 2025Buy Or Sell Opportunity • Apr 30Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to ₹412. The fair value is estimated to be ₹516, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Apr 07Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 18% to ₹409. The fair value is estimated to be ₹517, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Feb 11Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.3% to ₹434. The fair value is estimated to be ₹545, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Feb 08Third quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2025 results: ₹3.06 loss per share (improved from ₹5.65 loss in 3Q 2024). Revenue: ₹10.7b (up 20% from 3Q 2024). Net loss: ₹488.2m (loss narrowed 45% from 3Q 2024). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 112 percentage points per year, which is a significant difference in performance.공고 • Jan 30Chemplast Sanmar Limited to Report Q3, 2025 Results on Feb 07, 2025Chemplast Sanmar Limited announced that they will report Q3, 2025 results on Feb 07, 2025Reported Earnings • Nov 06Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2025 results: ₹1.95 loss per share (down from ₹1.65 profit in 2Q 2024). Revenue: ₹10.0b (up 1.6% from 2Q 2024). Net loss: ₹312.6m (down 220% from profit in 2Q 2024). Revenue missed analyst estimates by 6.6%. Earnings per share (EPS) exceeded analyst estimates by 35%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.공고 • Oct 31Chemplast Sanmar Limited to Report Q2, 2025 Results on Nov 05, 2024Chemplast Sanmar Limited announced that they will report Q2, 2025 results on Nov 05, 2024공고 • Aug 02Chemplast Sanmar Limited to Report Q1, 2025 Results on Aug 07, 2024Chemplast Sanmar Limited announced that they will report Q1, 2025 results on Aug 07, 2024Reported Earnings • Jul 15Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: ₹10.02 loss per share (down from ₹9.64 profit in FY 2023). Revenue: ₹39.2b (down 21% from FY 2023). Net loss: ₹1.58b (down 204% from profit in FY 2023). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 31%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in India.공고 • Jun 21Chemplast Sanmar Limited announced a financing transactionChemplast Sanmar Limited announced a private placement to issue equity shares or any other securities convertible into equity shares including warrants or otherwise and/or any other eligible securities through preferential allotment on June 19, 2024. The transaction is subject to approval of the shareholders and receipt of regulatory/statutory and other approvals as applicable.Price Target Changed • Jun 19Price target increased by 8.8% to ₹582Up from ₹535, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₹581. Stock is up 30% over the past year. The company is forecast to post earnings per share of ₹14.05 next year compared to a net loss per share of ₹10.02 last year.Buy Or Sell Opportunity • May 28Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 1.5% to ₹476. The fair value is estimated to be ₹395, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 3.5% over the last 3 years. Meanwhile, the company became loss making.공고 • May 23Chemplast Sanmar Limited, Annual General Meeting, Aug 08, 2024Chemplast Sanmar Limited, Annual General Meeting, Aug 08, 2024, at 16:20 Indian Standard Time.Reported Earnings • May 21Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: ₹10.02 loss per share (down from ₹9.64 profit in FY 2023). Revenue: ₹40.0b (down 19% from FY 2023). Net loss: ₹1.58b (down 204% from profit in FY 2023). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 31%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India.공고 • May 16Chemplast Sanmar Limited to Report Q4, 2024 Results on May 20, 2024Chemplast Sanmar Limited announced that they will report Q4, 2024 results on May 20, 2024Reported Earnings • Feb 13Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: ₹5.65 loss per share (down from ₹1.72 profit in 3Q 2023). Revenue: ₹9.01b (down 24% from 3Q 2023). Net loss: ₹893.8m (down 429% from profit in 3Q 2023). Revenue missed analyst estimates by 14%. Earnings per share (EPS) also missed analyst estimates by 95%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India.공고 • Feb 03Chemplast Sanmar Limited to Report Q3, 2024 Results on Feb 12, 2024Chemplast Sanmar Limited announced that they will report Q3, 2024 results on Feb 12, 2024Price Target Changed • Nov 04Price target decreased by 7.1% to ₹568Down from ₹612, the current price target is an average from 3 analysts. New target price is 27% above last closing price of ₹447. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₹12.40 for next year compared to ₹9.64 last year.Reported Earnings • Nov 03Second quarter 2024 earnings released: EPS: ₹1.65 (vs ₹2.44 in 2Q 2023)Second quarter 2024 results: EPS: ₹1.65 (down from ₹2.44 in 2Q 2023). Revenue: ₹10.2b (down 14% from 2Q 2023). Net income: ₹260.5m (down 32% from 2Q 2023). Profit margin: 2.5% (down from 3.2% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India.공고 • Oct 26Chemplast Sanmar Limited to Report Q2, 2024 Results on Nov 02, 2023Chemplast Sanmar Limited announced that they will report Q2, 2024 results on Nov 02, 2023Price Target Changed • Aug 14Price target decreased by 8.1% to ₹585Down from ₹637, the current price target is an average from 3 analysts. New target price is 32% above last closing price of ₹443. Stock is down 3.6% over the past year. The company is forecast to post earnings per share of ₹36.00 for next year compared to ₹9.64 last year.Buying Opportunity • Aug 10Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 1.8%. The fair value is estimated to be ₹564, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 7.2%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings is also forecast to grow by 42% per annum over the same time period.공고 • Aug 03Chemplast Sanmar Limited to Report Q1, 2024 Results on Aug 10, 2023Chemplast Sanmar Limited announced that they will report Q1, 2024 results on Aug 10, 2023Reported Earnings • Jul 19Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: ₹9.64 (down from ₹43.66 in FY 2022). Revenue: ₹49.4b (down 16% from FY 2022). Net income: ₹1.52b (down 77% from FY 2022). Profit margin: 3.1% (down from 11% in FY 2022). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 31%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10.0% growth forecast for the Chemicals industry in India.공고 • May 17+ 1 more updateChemplast Sanmar Limited, Annual General Meeting, Aug 11, 2023Chemplast Sanmar Limited, Annual General Meeting, Aug 11, 2023.공고 • May 10Chemplast Sanmar Limited Announces Resignation of Amarnath Ananthanarayanan to Board of DirectorsChemplast Sanmar Limited announced that Dr. Amarnath Ananthanarayanan, Non-Executive Non Independent Director, has resigned from Board of Directors of the Company with effect from May 09, 2023, due to his other pre-occupations. Date of Cessation: May 09, 2023.Reported Earnings • Feb 12Third quarter 2023 earnings: EPS and revenues exceed analyst expectationsThird quarter 2023 results: EPS: ₹1.72 (down from ₹14.98 in 3Q 2022). Revenue: ₹11.9b (down 18% from 3Q 2022). Net income: ₹271.4m (down 89% from 3Q 2022). Profit margin: 2.3% (down from 16% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 5.5%. Earnings per share (EPS) also surpassed analyst estimates by 91%. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India.공고 • Feb 05Chemplast Sanmar Limited to Report Q3, 2023 Results on Feb 11, 2023Chemplast Sanmar Limited announced that they will report Q3, 2023 results at 12:08 PM, Indian Standard Time on Feb 11, 2023Price Target Changed • Nov 16Price target decreased to ₹623Down from ₹753, the current price target is an average from 2 analysts. New target price is 61% above last closing price of ₹388. Stock is down 39% over the past year. The company is forecast to post earnings per share of ₹12.10 for next year compared to ₹43.66 last year.Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. No highly experienced directors. Non-Executive Director Amar Ananthanarayanan is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Major Estimate Revision • Nov 12Consensus EPS estimates fall by 47%The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from ₹56.9b to ₹51.7b. EPS estimate also fell from ₹22.80 per share to ₹12.10 per share. Net income forecast to shrink 34% next year vs 25% growth forecast for Chemicals industry in India . Consensus price target down from ₹753 to ₹623. Share price rose 4.7% to ₹383 over the past week.Reported Earnings • Nov 05Second quarter 2023 earnings: EPS exceeds analyst expectationsSecond quarter 2023 results: EPS: ₹2.44 (down from ₹10.51 in 2Q 2022). Revenue: ₹12.1b (down 28% from 2Q 2022). Net income: ₹385.4m (down 75% from 2Q 2022). Profit margin: 3.2% (down from 9.0% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates. Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India.Price Target Changed • Oct 14Price target decreased to ₹753Down from ₹843, the current price target is an average from 2 analysts. New target price is 89% above last closing price of ₹398. Stock is down 48% over the past year. The company is forecast to post earnings per share of ₹22.80 for next year compared to ₹43.66 last year.Major Estimate Revision • Aug 16Consensus EPS estimates fall by 49%The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from ₹59.7b to ₹56.9b. EPS estimate also fell from ₹44.50 per share to ₹22.80 per share. Net income forecast to shrink 33% next year vs 20% growth forecast for Chemicals industry in India . Consensus price target down from ₹880 to ₹843. Share price fell 2.2% to ₹460 over the past week.Reported Earnings • Aug 07First quarter 2023 earnings released: EPS: ₹2.57 (vs ₹6.48 in 1Q 2022)First quarter 2023 results: EPS: ₹2.57 (down from ₹6.48 in 1Q 2022). Revenue: ₹14.3b (up 8.4% from 1Q 2022). Net income: ₹405.9m (down 55% from 1Q 2022). Profit margin: 2.8% (down from 6.8% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 4.9% compared to a 14% growth forecast for the industry in India.공고 • Jul 30Chemplast Sanmar Limited to Report Q1, 2023 Results on Aug 05, 2022Chemplast Sanmar Limited announced that they will report Q1, 2023 results on Aug 05, 2022Valuation Update With 7 Day Price Move • Jun 17Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹393, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 23x in the Chemicals industry in India.Reported Earnings • May 13Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: ₹43.66 (up from ₹30.60 in FY 2021). Revenue: ₹58.9b (up 55% from FY 2021). Net income: ₹6.49b (up 58% from FY 2021). Profit margin: 11% (in line with FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.2%. Over the next year, revenue is forecast to grow 1.6%, compared to a 20% growth forecast for the industry in India.공고 • May 12Chemplast Sanmar Limited, Annual General Meeting, Jun 24, 2022Chemplast Sanmar Limited, Annual General Meeting, Jun 24, 2022. Agenda: To consider the appointment of M/ s B S R & Co. LLP as the Statutory Auditors of the Company for a period of 5 years from the conclusion of the ensuing 38th Annual General Meeting till the conclusion of 43rd Annual General Meeting.공고 • May 07Chemplast Sanmar Limited to Report Q4, 2022 Results on May 10, 2022Chemplast Sanmar Limited announced that they will report Q4, 2022 results on May 10, 2022Board Change • Apr 27High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Independent Director Prasad Menon was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공고 • Apr 22Chemplast Sanmar Limited Announces Demise of N Sankar, Chairman EmeritusChemplast Sanmar Limited announced the passing away of Mr. N Sankar, Chairman Emeritus, on April 17, 2022 and consequently he ceased to be chairman Emeritus of the company with effect from that date.Reported Earnings • Jan 30Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2022 results: EPS: ₹14.98 (down from ₹29.39 in 3Q 2021). Revenue: ₹14.5b (down 50% from 3Q 2021). Net income: ₹2.37b (down 40% from 3Q 2021). Profit margin: 16% (up from 14% in 3Q 2021). Revenue missed analyst estimates by 14%. Earnings per share (EPS) exceeded analyst estimates by 19%. Over the next year, revenue is forecast to grow 11%, compared to a 19% growth forecast for the industry in India.Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹520, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 27x in the Chemicals industry in India. Simply Wall St's valuation model estimates the intrinsic value at ₹393 per share.Reported Earnings • Nov 04Second quarter 2022 earnings released: EPS ₹10.51 (vs ₹29.39 in 2Q 2021)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹16.7b (down 43% from 2Q 2021). Net income: ₹1.51b (down 62% from 2Q 2021). Profit margin: 9.0% (down from 14% in 2Q 2021).Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹718, the stock trades at a trailing P/E ratio of 27.7x. Average trailing P/E is 20x in the Chemicals industry in India.Executive Departure • Sep 04Chief Financial Officer Meenakshisundaram Chandrasekar has left the companyOn the 31st of August, Meenakshisundaram Chandrasekar's tenure as Chief Financial Officer ended. We don't have any record of a personal shareholding under Meenakshisundaram's name. A total of 3 executives have left over the last 12 months.이익 및 매출 성장 예측BSE:543336 - 애널리스트 향후 추정치 및 과거 재무 데이터 (INR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수3/31/202957,0361,591N/A6,03523/31/202853,5151,0664,3928,45743/31/202747,973-737-1,0295,47943/31/202642,238-2,799-2182,943N/A12/31/202541,191-2,887N/AN/AN/A9/30/202543,415-2,183-2,7091,394N/A6/30/202543,011-1,985N/AN/AN/A3/31/202543,461-1,104-2,1061,717N/A12/31/202442,459-873N/AN/AN/A9/30/202440,765-1,279-3,529929N/A6/30/202440,715-706N/AN/AN/A3/31/202439,230-1,584-8,639-2,449N/A12/31/202340,191-812N/AN/AN/A9/30/202343,196353-7,746-1,240N/A6/30/202345,262478N/AN/AN/A3/31/202349,4111,524-6423,554N/A12/31/202256,0123,379N/AN/AN/A9/30/202258,6435,4765,4027,235N/A6/30/202263,4296,604N/AN/AN/A3/31/202258,9206,4877,8859,010N/A12/31/202154,2707,813N/AN/AN/A9/30/202150,6377,04316,17717,039N/A6/30/202140,7494,959N/AN/AN/A3/31/202137,9874,10110,21010,764N/A3/31/202012,5774611,1571,661N/A3/31/201912,5431,185N/A2,342N/A3/31/201830,2982,485N/A4,449N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 543336 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(6.9%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: 543336 (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: 543336 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: 543336 의 수익(연간 10.2%)이 Indian 시장(연간 11%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 543336 의 수익(연간 10.2%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 543336의 자본 수익률은 3년 후 8.7%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/29 13:44종가2026/07/29 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Chemplast Sanmar Limited는 4명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관null null360 ONE Capital Market Private LimitedAnkur PeriwalAxis Capital LimitedSanjesh JainICICI Securities Ltd.1명의 분석가 더 보기
Price Target Changed • May 27Price target decreased by 18% to ₹302Down from ₹366, the current price target is an average from 4 analysts. New target price is 36% above last closing price of ₹222. Stock is down 49% over the past year. The company is forecast to post a net loss per share of ₹3.17 next year compared to a net loss per share of ₹17.70 last year.
Price Target Changed • Feb 10Price target decreased by 12% to ₹380Down from ₹434, the current price target is an average from 4 analysts. New target price is 34% above last closing price of ₹283. Stock is down 35% over the past year. The company is forecast to post a net loss per share of ₹21.00 next year compared to a net loss per share of ₹6.98 last year.
Price Target Changed • Nov 18Price target decreased by 14% to ₹474Down from ₹553, the current price target is an average from 4 analysts. New target price is 45% above last closing price of ₹327. Stock is down 33% over the past year. The company is forecast to post a net loss per share of ₹5.55 next year compared to a net loss per share of ₹6.98 last year.
Price Target Changed • Oct 13Price target increased by 9.9% to ₹553Up from ₹503, the current price target is an average from 4 analysts. New target price is 51% above last closing price of ₹366. Stock is down 26% over the past year. The company is forecast to post earnings per share of ₹3.00 next year compared to a net loss per share of ₹6.98 last year.
Price Target Changed • Jun 19Price target increased by 8.8% to ₹582Up from ₹535, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₹581. Stock is up 30% over the past year. The company is forecast to post earnings per share of ₹14.05 next year compared to a net loss per share of ₹10.02 last year.
Price Target Changed • Nov 04Price target decreased by 7.1% to ₹568Down from ₹612, the current price target is an average from 3 analysts. New target price is 27% above last closing price of ₹447. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₹12.40 for next year compared to ₹9.64 last year.
Reported Earnings • Jul 16Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: ₹17.70 loss per share (further deteriorated from ₹6.98 loss in FY 2025). Revenue: ₹42.2b (down 2.8% from FY 2025). Net loss: ₹2.80b (loss widened 154% from FY 2025). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 4.3%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
Board Change • Jun 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. MD & Director S Ganeshkumar was the last director to join the board, commencing their role in 2026. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Price Target Changed • May 27Price target decreased by 18% to ₹302Down from ₹366, the current price target is an average from 4 analysts. New target price is 36% above last closing price of ₹222. Stock is down 49% over the past year. The company is forecast to post a net loss per share of ₹3.17 next year compared to a net loss per share of ₹17.70 last year.
공고 • May 26Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2026Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2026.
Reported Earnings • May 26Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: ₹17.70 loss per share (further deteriorated from ₹6.98 loss in FY 2025). Revenue: ₹42.5b (down 2.2% from FY 2025). Net loss: ₹2.80b (loss widened 154% from FY 2025). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 4.3%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.
공고 • May 19Chemplast Sanmar Limited to Report Q4, 2026 Results on May 25, 2026Chemplast Sanmar Limited announced that they will report Q4, 2026 results on May 25, 2026
Board Change • Apr 16Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. Non-Executive Independent Director Vikram Hosangady was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Buy Or Sell Opportunity • Mar 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.0% to ₹258. The fair value is estimated to be ₹325, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.1% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Feb 27Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 14% to ₹246. The fair value is estimated to be ₹307, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.1% over the last 3 years. Meanwhile, the company became loss making.
Price Target Changed • Feb 10Price target decreased by 12% to ₹380Down from ₹434, the current price target is an average from 4 analysts. New target price is 34% above last closing price of ₹283. Stock is down 35% over the past year. The company is forecast to post a net loss per share of ₹21.00 next year compared to a net loss per share of ₹6.98 last year.
Reported Earnings • Feb 09Third quarter 2026 earnings: EPS and revenues miss analyst expectationsThird quarter 2026 results: ₹7.45 loss per share (further deteriorated from ₹3.06 loss in 3Q 2025). Revenue: ₹8.35b (down 21% from 3Q 2025). Net loss: ₹1.19b (loss widened 144% from 3Q 2025). Revenue missed analyst estimates by 26%. Earnings per share (EPS) also missed analyst estimates by 28%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance.
공고 • Feb 02Chemplast Sanmar Limited to Report Q3, 2026 Results on Feb 07, 2026Chemplast Sanmar Limited announced that they will report Q3, 2026 results at 12:08 PM, Indian Standard Time on Feb 07, 2026
New Risk • Jan 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.4% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change).
Price Target Changed • Nov 18Price target decreased by 14% to ₹474Down from ₹553, the current price target is an average from 4 analysts. New target price is 45% above last closing price of ₹327. Stock is down 33% over the past year. The company is forecast to post a net loss per share of ₹5.55 next year compared to a net loss per share of ₹6.98 last year.
공고 • Nov 11Chemplast Sanmar Limited to Report Q2, 2026 Results on Nov 13, 2025Chemplast Sanmar Limited announced that they will report Q2, 2026 results at 12:08 PM, Indian Standard Time on Nov 13, 2025
공고 • Oct 28Chemplast Sanmar Limited to Report Q2, 2026 Results on Nov 04, 2025Chemplast Sanmar Limited announced that they will report Q2, 2026 results on Nov 04, 2025
Price Target Changed • Oct 13Price target increased by 9.9% to ₹553Up from ₹503, the current price target is an average from 4 analysts. New target price is 51% above last closing price of ₹366. Stock is down 26% over the past year. The company is forecast to post earnings per share of ₹3.00 next year compared to a net loss per share of ₹6.98 last year.
공고 • Jul 22Chemplast Sanmar Limited to Report Q1, 2026 Results on Jul 28, 2025Chemplast Sanmar Limited announced that they will report Q1, 2026 results on Jul 28, 2025
Reported Earnings • Jul 22Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: ₹6.98 loss per share (improved from ₹10.02 loss in FY 2024). Revenue: ₹43.5b (up 11% from FY 2024). Net loss: ₹1.10b (loss narrowed 30% from FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 65%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance.
공고 • May 14Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2025Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2025.
Reported Earnings • May 14Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: ₹6.92 loss per share (improved from ₹10.02 loss in FY 2024). Revenue: ₹43.9b (up 12% from FY 2024). Net loss: ₹1.10b (loss narrowed 30% from FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 65%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 114 percentage points per year, which is a significant difference in performance.
공고 • May 10Chemplast Sanmar Limited to Report Q4, 2025 Results on May 13, 2025Chemplast Sanmar Limited announced that they will report Q4, 2025 results on May 13, 2025
Buy Or Sell Opportunity • Apr 30Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to ₹412. The fair value is estimated to be ₹516, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Apr 07Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 18% to ₹409. The fair value is estimated to be ₹517, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Feb 11Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.3% to ₹434. The fair value is estimated to be ₹545, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Feb 08Third quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2025 results: ₹3.06 loss per share (improved from ₹5.65 loss in 3Q 2024). Revenue: ₹10.7b (up 20% from 3Q 2024). Net loss: ₹488.2m (loss narrowed 45% from 3Q 2024). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 112 percentage points per year, which is a significant difference in performance.
공고 • Jan 30Chemplast Sanmar Limited to Report Q3, 2025 Results on Feb 07, 2025Chemplast Sanmar Limited announced that they will report Q3, 2025 results on Feb 07, 2025
Reported Earnings • Nov 06Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2025 results: ₹1.95 loss per share (down from ₹1.65 profit in 2Q 2024). Revenue: ₹10.0b (up 1.6% from 2Q 2024). Net loss: ₹312.6m (down 220% from profit in 2Q 2024). Revenue missed analyst estimates by 6.6%. Earnings per share (EPS) exceeded analyst estimates by 35%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.
공고 • Oct 31Chemplast Sanmar Limited to Report Q2, 2025 Results on Nov 05, 2024Chemplast Sanmar Limited announced that they will report Q2, 2025 results on Nov 05, 2024
공고 • Aug 02Chemplast Sanmar Limited to Report Q1, 2025 Results on Aug 07, 2024Chemplast Sanmar Limited announced that they will report Q1, 2025 results on Aug 07, 2024
Reported Earnings • Jul 15Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: ₹10.02 loss per share (down from ₹9.64 profit in FY 2023). Revenue: ₹39.2b (down 21% from FY 2023). Net loss: ₹1.58b (down 204% from profit in FY 2023). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 31%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in India.
공고 • Jun 21Chemplast Sanmar Limited announced a financing transactionChemplast Sanmar Limited announced a private placement to issue equity shares or any other securities convertible into equity shares including warrants or otherwise and/or any other eligible securities through preferential allotment on June 19, 2024. The transaction is subject to approval of the shareholders and receipt of regulatory/statutory and other approvals as applicable.
Price Target Changed • Jun 19Price target increased by 8.8% to ₹582Up from ₹535, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₹581. Stock is up 30% over the past year. The company is forecast to post earnings per share of ₹14.05 next year compared to a net loss per share of ₹10.02 last year.
Buy Or Sell Opportunity • May 28Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 1.5% to ₹476. The fair value is estimated to be ₹395, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 3.5% over the last 3 years. Meanwhile, the company became loss making.
공고 • May 23Chemplast Sanmar Limited, Annual General Meeting, Aug 08, 2024Chemplast Sanmar Limited, Annual General Meeting, Aug 08, 2024, at 16:20 Indian Standard Time.
Reported Earnings • May 21Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: ₹10.02 loss per share (down from ₹9.64 profit in FY 2023). Revenue: ₹40.0b (down 19% from FY 2023). Net loss: ₹1.58b (down 204% from profit in FY 2023). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 31%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India.
공고 • May 16Chemplast Sanmar Limited to Report Q4, 2024 Results on May 20, 2024Chemplast Sanmar Limited announced that they will report Q4, 2024 results on May 20, 2024
Reported Earnings • Feb 13Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: ₹5.65 loss per share (down from ₹1.72 profit in 3Q 2023). Revenue: ₹9.01b (down 24% from 3Q 2023). Net loss: ₹893.8m (down 429% from profit in 3Q 2023). Revenue missed analyst estimates by 14%. Earnings per share (EPS) also missed analyst estimates by 95%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India.
공고 • Feb 03Chemplast Sanmar Limited to Report Q3, 2024 Results on Feb 12, 2024Chemplast Sanmar Limited announced that they will report Q3, 2024 results on Feb 12, 2024
Price Target Changed • Nov 04Price target decreased by 7.1% to ₹568Down from ₹612, the current price target is an average from 3 analysts. New target price is 27% above last closing price of ₹447. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₹12.40 for next year compared to ₹9.64 last year.
Reported Earnings • Nov 03Second quarter 2024 earnings released: EPS: ₹1.65 (vs ₹2.44 in 2Q 2023)Second quarter 2024 results: EPS: ₹1.65 (down from ₹2.44 in 2Q 2023). Revenue: ₹10.2b (down 14% from 2Q 2023). Net income: ₹260.5m (down 32% from 2Q 2023). Profit margin: 2.5% (down from 3.2% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India.
공고 • Oct 26Chemplast Sanmar Limited to Report Q2, 2024 Results on Nov 02, 2023Chemplast Sanmar Limited announced that they will report Q2, 2024 results on Nov 02, 2023
Price Target Changed • Aug 14Price target decreased by 8.1% to ₹585Down from ₹637, the current price target is an average from 3 analysts. New target price is 32% above last closing price of ₹443. Stock is down 3.6% over the past year. The company is forecast to post earnings per share of ₹36.00 for next year compared to ₹9.64 last year.
Buying Opportunity • Aug 10Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 1.8%. The fair value is estimated to be ₹564, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 7.2%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings is also forecast to grow by 42% per annum over the same time period.
공고 • Aug 03Chemplast Sanmar Limited to Report Q1, 2024 Results on Aug 10, 2023Chemplast Sanmar Limited announced that they will report Q1, 2024 results on Aug 10, 2023
Reported Earnings • Jul 19Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: ₹9.64 (down from ₹43.66 in FY 2022). Revenue: ₹49.4b (down 16% from FY 2022). Net income: ₹1.52b (down 77% from FY 2022). Profit margin: 3.1% (down from 11% in FY 2022). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 31%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10.0% growth forecast for the Chemicals industry in India.
공고 • May 17+ 1 more updateChemplast Sanmar Limited, Annual General Meeting, Aug 11, 2023Chemplast Sanmar Limited, Annual General Meeting, Aug 11, 2023.
공고 • May 10Chemplast Sanmar Limited Announces Resignation of Amarnath Ananthanarayanan to Board of DirectorsChemplast Sanmar Limited announced that Dr. Amarnath Ananthanarayanan, Non-Executive Non Independent Director, has resigned from Board of Directors of the Company with effect from May 09, 2023, due to his other pre-occupations. Date of Cessation: May 09, 2023.
Reported Earnings • Feb 12Third quarter 2023 earnings: EPS and revenues exceed analyst expectationsThird quarter 2023 results: EPS: ₹1.72 (down from ₹14.98 in 3Q 2022). Revenue: ₹11.9b (down 18% from 3Q 2022). Net income: ₹271.4m (down 89% from 3Q 2022). Profit margin: 2.3% (down from 16% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 5.5%. Earnings per share (EPS) also surpassed analyst estimates by 91%. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India.
공고 • Feb 05Chemplast Sanmar Limited to Report Q3, 2023 Results on Feb 11, 2023Chemplast Sanmar Limited announced that they will report Q3, 2023 results at 12:08 PM, Indian Standard Time on Feb 11, 2023
Price Target Changed • Nov 16Price target decreased to ₹623Down from ₹753, the current price target is an average from 2 analysts. New target price is 61% above last closing price of ₹388. Stock is down 39% over the past year. The company is forecast to post earnings per share of ₹12.10 for next year compared to ₹43.66 last year.
Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. No highly experienced directors. Non-Executive Director Amar Ananthanarayanan is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Major Estimate Revision • Nov 12Consensus EPS estimates fall by 47%The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from ₹56.9b to ₹51.7b. EPS estimate also fell from ₹22.80 per share to ₹12.10 per share. Net income forecast to shrink 34% next year vs 25% growth forecast for Chemicals industry in India . Consensus price target down from ₹753 to ₹623. Share price rose 4.7% to ₹383 over the past week.
Reported Earnings • Nov 05Second quarter 2023 earnings: EPS exceeds analyst expectationsSecond quarter 2023 results: EPS: ₹2.44 (down from ₹10.51 in 2Q 2022). Revenue: ₹12.1b (down 28% from 2Q 2022). Net income: ₹385.4m (down 75% from 2Q 2022). Profit margin: 3.2% (down from 9.0% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates. Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India.
Price Target Changed • Oct 14Price target decreased to ₹753Down from ₹843, the current price target is an average from 2 analysts. New target price is 89% above last closing price of ₹398. Stock is down 48% over the past year. The company is forecast to post earnings per share of ₹22.80 for next year compared to ₹43.66 last year.
Major Estimate Revision • Aug 16Consensus EPS estimates fall by 49%The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from ₹59.7b to ₹56.9b. EPS estimate also fell from ₹44.50 per share to ₹22.80 per share. Net income forecast to shrink 33% next year vs 20% growth forecast for Chemicals industry in India . Consensus price target down from ₹880 to ₹843. Share price fell 2.2% to ₹460 over the past week.
Reported Earnings • Aug 07First quarter 2023 earnings released: EPS: ₹2.57 (vs ₹6.48 in 1Q 2022)First quarter 2023 results: EPS: ₹2.57 (down from ₹6.48 in 1Q 2022). Revenue: ₹14.3b (up 8.4% from 1Q 2022). Net income: ₹405.9m (down 55% from 1Q 2022). Profit margin: 2.8% (down from 6.8% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 4.9% compared to a 14% growth forecast for the industry in India.
공고 • Jul 30Chemplast Sanmar Limited to Report Q1, 2023 Results on Aug 05, 2022Chemplast Sanmar Limited announced that they will report Q1, 2023 results on Aug 05, 2022
Valuation Update With 7 Day Price Move • Jun 17Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹393, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 23x in the Chemicals industry in India.
Reported Earnings • May 13Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: ₹43.66 (up from ₹30.60 in FY 2021). Revenue: ₹58.9b (up 55% from FY 2021). Net income: ₹6.49b (up 58% from FY 2021). Profit margin: 11% (in line with FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.2%. Over the next year, revenue is forecast to grow 1.6%, compared to a 20% growth forecast for the industry in India.
공고 • May 12Chemplast Sanmar Limited, Annual General Meeting, Jun 24, 2022Chemplast Sanmar Limited, Annual General Meeting, Jun 24, 2022. Agenda: To consider the appointment of M/ s B S R & Co. LLP as the Statutory Auditors of the Company for a period of 5 years from the conclusion of the ensuing 38th Annual General Meeting till the conclusion of 43rd Annual General Meeting.
공고 • May 07Chemplast Sanmar Limited to Report Q4, 2022 Results on May 10, 2022Chemplast Sanmar Limited announced that they will report Q4, 2022 results on May 10, 2022
Board Change • Apr 27High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Independent Director Prasad Menon was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공고 • Apr 22Chemplast Sanmar Limited Announces Demise of N Sankar, Chairman EmeritusChemplast Sanmar Limited announced the passing away of Mr. N Sankar, Chairman Emeritus, on April 17, 2022 and consequently he ceased to be chairman Emeritus of the company with effect from that date.
Reported Earnings • Jan 30Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2022 results: EPS: ₹14.98 (down from ₹29.39 in 3Q 2021). Revenue: ₹14.5b (down 50% from 3Q 2021). Net income: ₹2.37b (down 40% from 3Q 2021). Profit margin: 16% (up from 14% in 3Q 2021). Revenue missed analyst estimates by 14%. Earnings per share (EPS) exceeded analyst estimates by 19%. Over the next year, revenue is forecast to grow 11%, compared to a 19% growth forecast for the industry in India.
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹520, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 27x in the Chemicals industry in India. Simply Wall St's valuation model estimates the intrinsic value at ₹393 per share.
Reported Earnings • Nov 04Second quarter 2022 earnings released: EPS ₹10.51 (vs ₹29.39 in 2Q 2021)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹16.7b (down 43% from 2Q 2021). Net income: ₹1.51b (down 62% from 2Q 2021). Profit margin: 9.0% (down from 14% in 2Q 2021).
Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹718, the stock trades at a trailing P/E ratio of 27.7x. Average trailing P/E is 20x in the Chemicals industry in India.
Executive Departure • Sep 04Chief Financial Officer Meenakshisundaram Chandrasekar has left the companyOn the 31st of August, Meenakshisundaram Chandrasekar's tenure as Chief Financial Officer ended. We don't have any record of a personal shareholding under Meenakshisundaram's name. A total of 3 executives have left over the last 12 months.